This inventor holds 3 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Rakesh Thummar: Innovator in Pharmaceutical Solutions
Introduction
Rakesh Thummar is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable injectable solutions. With a total of 3 patents to his name, Thummar's work is recognized for its innovative approach to drug formulation.
Latest Patents
Thummar's latest patents include a stable aqueous injectable solution of epinephrine. This invention provides a stable solution comprising epinephrine or its pharmaceutically acceptable salt, along with a sulfite antioxidant, butylated hydroxyl anisole, an organic acid, and a chelating agent. Notably, the solution is free of inorganic acids and bases. Additionally, he has developed a parenteral dosage form of norepinephrine, which is a ready-to-administer solution that remains stable at room temperature for an extended period. This formulation includes an antioxidant that is not a sulfite, enhancing its usability in medical settings.
Career Highlights
Rakesh Thummar is currently employed at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative drug delivery systems and formulations that improve patient outcomes.
Collaborations
Thummar has collaborated with several professionals in his field, including Subhas Balaram Bhowmick and Amar Rana. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Rakesh Thummar's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments through advanced drug formulations. His work continues to impact the industry positively, paving the way for future advancements in injectable solutions.
